Invention Grant
- Patent Title: Heterocyclic compound
-
Application No.: US15137161Application Date: 2016-04-25
-
Publication No.: US09890145B2Publication Date: 2018-02-13
- Inventor: Masato Yoshida , Kazuaki Takami , Yusuke Tominari , Zenyu Shiokawa , Akito Shibuya , Yusuke Sasaki , Tony Gibson , Terufumi Takagi
- Applicant: Takeda Pharmaceutical Company Limited
- Applicant Address: JP Osaka
- Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee: Takeda Pharmaceutical Company Limited
- Current Assignee Address: JP Osaka
- Agency: Foley & Lardner LLP
- Priority: JP2013-232571 20131108; JP2014-128562 20140623
- Main IPC: C07D401/14
- IPC: C07D401/14 ; C07D487/04 ; C07D417/14 ; C07D487/10 ; A61P37/00 ; C07D403/14 ; A61K31/4155 ; C07D413/14 ; C07D401/04 ; C07D409/14 ; C07D405/14 ; A61K9/06 ; A61K9/20 ; A61K9/48 ; C07D403/04 ; C07D471/04 ; C07D471/10 ; C07D491/107 ; C07D495/04
Abstract:
The present invention provides a heterocyclic compound having an IRAK-4 inhibitory action, which is useful for the prophylaxis or treatment of inflammatory disease, autoimmune disease, osteoarticular degenerative disease, neoplastic disease and the like, and a medicament containing thereof. The present invention relates to a compound represented by the formula (I): wherein each symbol is as defined in the specification, or a salt thereof.
Public/Granted literature
- US20160311811A1 HETEROCYCLIC COMPOUND Public/Granted day:2016-10-27
Information query
